Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Global chromatin landscapes identify candidate noncoding modifiers of cardiac rhythm
Samadrita Bhattacharyya, … , Ralf Kittler, Nikhil V. Munshi
Samadrita Bhattacharyya, … , Ralf Kittler, Nikhil V. Munshi
Published December 1, 2022
Citation Information: J Clin Invest. 2023;133(3):e153635. https://doi.org/10.1172/JCI153635.
View: Text | PDF
Research Article Cardiology

Global chromatin landscapes identify candidate noncoding modifiers of cardiac rhythm

  • Text
  • PDF
Abstract

Comprehensive cis-regulatory landscapes are essential for accurate enhancer prediction and disease variant mapping. Although cis-regulatory element (CRE) resources exist for most tissues and organs, many rare — yet functionally important — cell types remain overlooked. Despite representing only a small fraction of the heart’s cellular biomass, the cardiac conduction system (CCS) unfailingly coordinates every life-sustaining heartbeat. To globally profile the mouse CCS cis-regulatory landscape, we genetically tagged CCS component–specific nuclei for comprehensive assay for transposase-accessible chromatin–sequencing (ATAC-Seq) analysis. Thus, we established a global CCS-enriched CRE database, referred to as CCS-ATAC, as a key resource for studying CCS-wide and component-specific regulatory functions. Using transcription factor (TF) motifs to construct CCS component–specific gene regulatory networks (GRNs), we identified and independently confirmed several specific TF sub-networks. Highlighting the functional importance of CCS-ATAC, we also validated numerous CCS-enriched enhancer elements and suggested gene targets based on CCS single–cell RNA-Seq data. Furthermore, we leveraged CCS-ATAC to improve annotation of existing human variants related to cardiac rhythm and nominated a potential enhancer-target pair that was dysregulated by a specific SNP. Collectively, our results established a CCS-regulatory compendium, identified novel CCS enhancer elements, and illuminated potential functional associations between human genomic variants and CCS component–specific CREs.

Authors

Samadrita Bhattacharyya, Rahul K. Kollipara, Gabriela Orquera-Tornakian, Sean Goetsch, Minzhe Zhang, Cameron Perry, Boxun Li, John M. Shelton, Minoti Bhakta, Jialei Duan, Yang Xie, Guanghua Xiao, Bret M. Evers, Gary C. Hon, Ralf Kittler, Nikhil V. Munshi

×

Figure 4

Defining CCS component-specific enhancers.

Options: View larger image (or click on image) Download as PowerPoint
Defining CCS component-specific enhancers.
(A) Schematic showing enhance...
(A) Schematic showing enhancer validation workflow. Distal chromatin accessibility regions for individual CCS- or CM-ATAC data sets were compared with ENCODE H-H3K27Ac annotations across development to identify CCS enhancers (see Methods for details). Bar graph indicates percentage overlap between H-H3K27Ac regions and individual CCS and CM data sets. Flowchart outlines how specific CCS enhancers were chosen for histological validation (see Supplemental Figure 14). (B) Genome browser view of SAN-candidate enhancer element mm1326, which lies within an intron of the Btbd9 gene. Transverse section through mm1326 transgenic mouse embryo showing LacZ expression in the region of sinus horn myocardium (blue arrows). Previously published in situ hybridization analyses of an E10.5 embryo showing Tbx18 expression in sinus horn myocardium (red arrows) (52). (C) SAN expression of genes within ±500kb of mm1326 are indicated by solid box (left). Uniform Manifold Approximation and Projection (UMAP) plot of Btbd9 gene overlaid upon SAN scRNA-Seq atlas (right). SAN (blue) and transitional (brown) cells are indicated. (D) Immunofluorescence analysis showing Btbd9 expression in P0 Shox2Cre/+;R26tdTomato/+ mouse heart cryosection. Arrow indicates Btbd9 expression in SAN region. Zoomed inset shows overlap of tdTomato and Btbd9 signals. (E) Box-and-whiskers plot showing decreased PR interval (using 1-way ANOVA) in Btbd9 KO mice compared with controls. (F) Bar graph representing RLUs for mm1326 enhancer relative to empty-luciferase construct in primary mouse SAN cells. (G) Genome browser view of AVN-candidate enhancer element hs2384, which lies intergenic to the Rhob and Hs1bp3 genes. Transverse section through hs2384 transgenic mouse embryo showing LacZ expression in the AVC myocardium and cushion mesenchyme (red arrows). Previous report of X-Gal-stained Cx30.2-lacZ transgenic E11.5 embryo with expression in AVC myocardium (25) (arrows). (H) AVN expression of genes within ± 500 kb of hs2384 are indicated by solid box (left). UMAP plot of Laptm4a gene overlaid upon AVCS scRNA-Seq atlas (right). AVN cells are indicated (red). (I) Immunofluorescence analysis showing Laptm4a expression in P4 Gjd3Cre/+;R26tdTomato/+ mouse heart cryosection. Arrowheads indicate expression of Laptm4a adjacent to tdTomato in transitional cells of the atrial septum and proximal AVN. (J) Box-and-whiskers plot demonstrating QTc prolongation (using 1-way ANOVA) in Laptm4a KO mice compared with controls. (K) Bar graph representing RLUs for hs2384 enhancer relative to empty-luciferase construct in primary mouse AVCS cells. Data were analyzed via 2-tailed paired t test. Error bars illustrate SEM of luciferase expression between 2 independent experiments. (L) Genome browser view of VCS-candidate enhancer element hs1932, which lies within an intron of the Igf1r gene. Transverse section through hs1932 transgenic mouse embryo showing LacZ expression in the presumptive AVB (green arrowheads) and Purkinje fibers (dotted arrow). Expression of CCS-LacZ in E10.5 mouse heart (75) is shown as a reference. (M) AVB expression of genes within ± 500 kb of hs1932 are indicated by solid box. UMAP plot of Mef2a gene overlaid upon AVCS scRNA-Seq atlas. Cells comprising proximal AVB are indicated (green). (N) Immunofluorescence analysis showing Mef2a expression in P28 Cntn2Cre/+;R26tdTomato/+ mouse heart cryosection. Arrowheads indicate overlap of tdTomato and Mef2a in the AVB and RBB. (O) Bar graph representing RLUs for hs1932 enhancer compared with empty-luciferase construct in primary mouse AVCS cells. RA, right atrium; LA, left atrium; RV, right ventricle; LV, left ventricle. P values were determined by 2-tailed paired t tests. *P < 0.05; **P < 0.01; ***P < 0.005. Error bars illustrate SEM of luciferase expression between 2 independent experiments.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts